Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Qureight accelerates drug development for lung and heart diseases by curating and analyzing clinical imaging and related data to create measurable endpoints. The company provides an AI-enabled…

Qureight accelerates drug development for lung and heart diseases by curating and analyzing clinical imaging and related data to create measurable endpoints. The company provides an AI-enabled…
What they do: AI-enabled imaging CRO that curates clinical imaging and delivers precision endpoints for lung and heart trials
Headquarters: Cambridge, UK
Founded: 2018
Employees: 56
Total funding: USD 11,164,471
Clinical-trial imaging, data curation and quantitative endpoints for interstitial/fibrotic lung diseases and pulmonary/left-heart conditions (e.g., IPF, PPF, PH, bronchiectasis).
2018
Biotechnology
USD 11,164,471
Company linked in databases to investors including Ascension, Ascension Life Fund, CMS Ventures, Cambridge Angels group, Guinness Ventures, Hargreave Hale Aim VCT, Meltwind Advisory, Nexenai Capital, Playfair Capital, XTX Ventures
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
81,000+
Open Roles
4,500+
New This Week
| Company |
|---|